Preliminary experience with the angiotensin II receptor antagonist irbesartan in chronic kidney disease

European Journal of Pediatrics

Volumn 159, Issue 8, 2000, Pages 590-593

  Von Vigier, Rodo O ^a   Zberg, Priska M ^a   Teuffel, Oliver ^a   Bianchetti, Mario G ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

Angiotensin II antagonist; Hypertension; Irbesartan; Kidney disease; Proteinuria

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; IRBESARTAN;

ADOLESCENT; ANTIHYPERTENSIVE THERAPY; ARTICLE; CHILD; CHRONIC KIDNEY DISEASE; CLINICAL ARTICLE; CREATININE URINE LEVEL; DRUG EFFECT; HUMAN; PRIORITY JOURNAL; PROTEINURIA; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

ADOLESCENT; ANGIOTENSIN II; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; BIPHENYL COMPOUNDS; BLOOD PRESSURE; CHILD; CHILD, PRESCHOOL; CHRONIC DISEASE; FEMALE; HUMANS; KIDNEY DISEASES; MALE; PROTEINURIA; RECEPTORS, ANGIOTENSIN; RENIN-ANGIOTENSIN SYSTEM; TETRAZOLES; TREATMENT OUTCOME;

EID: 0033914279     PISSN: 03406199     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004310000495     Document Type: Article

References (11)

1. Burgess E (1999) Conservative treatment to slow deterioration of renal function: evidence-based recommendations. Kidney Int 70[Suppl]: S17-S25
2. Gruskin AB, Dabbagh S, Fleishmann LE, Atiyeh BA (1994) Application since 1980 of antihypertensive agents to treat pediatric disease. J Hum Hypertens 8: 381-388
3. Mackenzie HS, Ziai F, Omer SA, Nadim MK, Taal MW (1999) Angiotensin receptor blockers in chronic renal disease: the promise of a bright clinical future. J Am Soc Nephrol 10[Suppl 12]: S283-S286
4. National High Blood Pressure Education Program Working Group on Hypertension Control in Children and Adolescents (1996) Update on the 1987 task force report on high blood pressure in children and adolescents: a working group report from the national high blood pressure education program. Pediatrics 98: 649-658
5. Perico N, Remuzzi A, Sangalli F, Azzollini N, Mister M, Ruggenenti P, Remuzzi G (1998) The antiproteinuric effect of angiotensin antagonism in human IgA nepropathy is potentiated by indomethacin. J Am Soc Nephrol 9: 2308-2317
6. Pylypchuk GB (1998) ACE inhibitor- versus angiotensin II blocker-induced cough and angioedema. Ann Pharmacother 32: 1060-1066
7. Schwartz GJ, Haycock GB, Spitzer A (1976) Plasma creatinine and urea concentration in children: normal values for age and sex. J Pediatr 88: 828-830
8. von Vigier RO, Mozzettini S, Truttmann AC, Meregalli P, Ramelli GP, Bianchetti MG (2000) Cough is common in children prescribed converting enzyme inhibitors. Nephron 84: 98
9. Waeber B, Brunner HR (1998) A look through the new therapeutic window: irbesartan. J Hypertens 16[Suppl]: 11-16
10. Weber MA (1997) Comparison of type 1 angiotensin II receptor blockers and angiotensin converting enzyme inhibitors in the treatment of hypertension. J Hypertens 15[Suppl]: S31-S36
11. World Health Organisation Guidlines Subcommittee (1999) International society of hypertension guidelines for the management of hypertension. Blood Press 1[Suppl]: 9-43